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Abstract
Pterygium is a lesion of the eye surface which involves cell proliferation, migration, angiogenesis, fibrosis, and extracellular
matrix remodelling. Surgery is the only approved method to treat this disorder, but high recurrence rates are common.
Recently, it has been shown in a mouse model that treatment with doxycycline resulted in reduction of the pterygium
lesions. Here we study the mechanism(s) of action by which doxycycline achieves these results, using massive sequencing
techniques. Surgically removed pterygia from 10 consecutive patients were set in short term culture and exposed to 0
(control), 50, 200, and 500 mg/ml doxycycline for 24 h, their mRNA was purified, reverse transcribed and sequenced through
Illumina’s massive sequencing protocols. Acquired data were subjected to quantile normalization and analyzed using
cytoscape plugin software to explore the pathways involved. False discovery rate (FDR) methods were used to identify 332
genes which modified their expression in a dose-dependent manner upon exposure to doxycycline. The more represented
cellular pathways included all mitochondrial genes, the endoplasmic reticulum stress response, integrins and extracellular
matrix components, and growth factors. A high correlation was obtained when comparing ultrasequencing data with qRT-
PCR and ELISA results. Doxycycline significantly modified the expression of important cellular pathways in pterygium cells,
in a way which is consistent with the observed efficacy of this antibiotic to reduce pterygium lesions in a mouse model.
Clinical trials are under way to demonstrate whether there is a benefit for human patients.
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Introduction
Pterygium is a very common ocular surface lesion attributed to
chronic ultraviolet light exposure which typically afflicts a younger
population, adding tremendous burden, both human and finan-
cial, in many countries [1]. At the cellular level, pterygium is
characterized by proliferation of limbal cells, inflammatory
infiltrates, fibrosis, angiogenesis, and extracellular matrix break-
down [2–4]. Traditionally regarded as a degenerative condition,
pterygia also display tumor-like features, such as propensity to
invade normal tissue and high recurrence rates following resection
[5]. The mechanism of pterygium formation is not completely
understood but several processes have been suggested as part of
the pathogenesis of this disease, including genetic predisposition,
anti-apoptotic mechanisms, cytokines, growth factors, extracellular
matrix remodelling, immunological mechanisms, and viral infec-
tions [6].
Currently, the only approved treatment for pterygium is surgery
[7], a group of different procedures that, in some cases, result in
high recurrence rates [8]. Recently, based on the profuse irrigation
of the pterygium lesion, bevacizumab-mediated antiangiogenic
therapies have been tested, but these protocols have produced
inconclusive results [9,10].
In a recent article, it was shown that doxycycline, a common
oral antibiotic, was able to dramatically reduce pterygium-like
lesions in a mouse model [11]. The same antibiotic was
responsible for reducing neovascularisation in a burn model of
the rat cornea [12]. Apparently, doxycycline and other tetracy-
clines posses numerous properties which are independent of their
antibiotic activity [13]. Specifically, the antiangiogenic effects of
doxycycline seem to be related with the inhibition of matrix
metalloproteinases [14,15], although alternative and/or synergistic
mechanisms cannot be excluded.
In the present study we decided to investigate the molecular
effects of doxycycline on short-term primary cultures of pterygium
cells, using ultrasequencing techniques, to better understand all the
pathways affected by the antibiotic in pterygium.
Results
Primary cultures were established from pterygia surgically
removed from 10 patients. To identify the cell population present
in these cultures, immunofluorescence for different markers was
performed. Confocal microscopy of these samples showed that the
predominant cell population is composed of vimentin-positive
cells, with a fibroblast-compatible morphology (Fig. 1).
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39359The cultures were treated with doxycycline and RNA from
these samples was analyzed through massive sequencing. Due to
the characteristics of the multiplexing protocol and other technical
reasons, there was a broad variability on the number of sequence
readings per sample, ranging from 82,040 to more than 7.5 million
reads (Fig. 2). To deal with this variability, ultrasequencing data
were normalized in all samples. To test the efficacy of our
normalization protocol, several predictions were made and
checked on the data pool. One of the tests consisted in the
prediction of the patient’s gender by analyzing expression of genes
coded by the Y chromosome (Fig. 3A,B) or other genes whose
expression is linked to the sex of the individual, such as XIST or
RPS4Y1 (not shown). The gender of all patients was correctly
predicted. A second test consisted in the analysis of genes whose
expression was not modified by doxycycline treatment. In these
cases, the genetic background of each patient was very homoge-
neous in comparison with the expression in other patients, which
was more variable (Fig. 3C-H).
Following normalization, the first observation was a confirma-
tion of the predominant cell type in the cultures. Several fibroblast
markers, including fibronectin 1, collagen type1 a and b, vimentin,
and collagen type 3, were found among the 10 most represented
transcripts of the study, whereas markers for endothelial and
epithelial cells were very scarce.
Then, gene expression of samples treated with doxycycline was
compared with untreated controls. A Manhattan-type heatmap for
the 332 genes whose expression experimented the largest variation
after antibiotic treatment shows that treatments tend to group
together, indicating that for these genes variations due to the
treatment are larger than those due to individual idiosyncrasies
(Fig. 4).
To investigate which cellular pathways are involved in the
response of pterygium cells to doxycycline, ultrasequencing results
were analyzed with specialized software. The group of genes that
experiment larger variations after treatment with the antibiotic are
the ones expressed by the mitochondrial genome. Eukaryotic
mitochondrial DNA codes for 15 major genes; of these, a single
gene (MT-ATP8) did not change, expression for the 2 genes
coding for ribosomal RNA was highly upregulated in a dose-
dependent manner after treatment, whereas expression for the
other 12 genes was downregulated, also in a dose-dependent
fashion (Table 1).
Another pathway whose expression was deeply modified (all
genes in this pathway were upregulated) upon doxycycline
treatment includes almost all the proteins involved in the
endoplasmic reticulum (ER) stress response (Fig. 5). This pathway
is implicated at all levels, from the docking of the ribosome to the
ER (SSR2, RRBP1, SEC61A1), to proteins involved in protein
Figure 1. Confocal image of pterygium cells in culture stained with antibodies against vimentin (green), CD31 (white), and keratin 4
(red). DAPI was used as a nuclear counterstain (blue). All cells were vimentin-positive and no immunoreactivity was found for markers of epithelial or
endothelial lineages. Bar=20 mm.
doi:10.1371/journal.pone.0039359.g001
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SIL1, HSP47), members of the unfolded protein response (ATF6,
IRE1, PERK), and the ER-associated protein degradation
(ERAD) process (EDEM1, SEC61, ubiquitin ligase complex,
etc). When the unfolded protein response (UPR) is activated,
several mediator signals are sent to the nucleus to activate UPR
responsive genes and to promote apoptosis. One of these is
CHOP, which is also upregulated in doxycycline treated cells.
Another set of genes affected by doxycycline treatment includes
several integrins, integrin-interacting proteins, collagens, and other
extracellular matrix components (Table 2), indicating that
doxycycline has a significant impact on matrix remodelling. In
addition, several growth factors including VEGF and MANF,
cytokines such as IL-6, and cell cycle related factors (TP53,
CDKN1A, CDK2AP2) had also modified expression in the
doxycycline treated cells.
Sequencing results were confirmed through quantitative real
time PCR (qRT-PCR) for those pathways with higher degrees of
variation upon treatment. In all cases, the direction and magnitude
of the change in expression was confirmed by the amplification
technique (Fig. 6). For all the chosen genes, there was a tight
correlation between data obtained through ultrasequencing and
those collected by real time PCR (Fig. 7), indicating the efficiency
of our normalization method.
For some genes that generate secretory proteins, such as
MANF, IL-6, and VEGFA, a further confirmation was performed
through ELISA protein determination in the supernatant of the
treated and untreated cultures. Again, a high correlation was
observed among sequencing data, qRT-PCR quantification, and
ELISA protein levels (Fig. 8).
Discussion
In this study we have shown through ultrasequencing analysis
that pterygium cells respond to doxycycline treatment by
modifying the expression levels of a broad number of genes
responsible for important cellular functions. Among the pathways
that were modified the most, we found the mitochondrial genes,
the ER stress cascade, growth factors, interleukins, cell cycle
regulators, integrins, and components of the extracellular matrix.
Data Normalization
Massive transcriptome sequencing is a relatively new technique
and, as such, needs some time and a series of additional
developments before its complete potential can be achieved. In
this regard, data normalization is one of the most relevant
problems in current papers dealing with ultrasequencing data.
Initially it was presumed that RNA-seq techniques were free of the
nonlinear distortions that plagued hybridization techniques.
Hence expression values were derived directly from the total
number of alignments for a particular exon divided by its length
[16]. Later on, that measurement was improved by the Reads Per
Kilobase of exon model per Million mapped reads (RPKM)
method [17]. Still, these and similar methods were affected by an
important sequencing depth bias. Nowadays, novel normalization
methods are appearing to deal with all these problems [18].
Our normalization protocol uses the broad experience accrued
in the last years from microarray analysis, where quantile
normalization has been the gold standard [19]. This approach
does not introduce substantial biases in either genes with low
expression nor in those with high expression levels. Confirmation
of the quality of our approach is provided by a series of biological
evidences. First, our data predicted correctly the gender of all the
patients based on the expression of genes coded by the Y
chromosome. Second, genes whose expression is bound to the
sample genetic background were clearly differentiated with this
method. In addition, expression data obtained by addition of
sequencing alignments presented a high correlation with data
obtained from the same samples by qRT-PCR. An outstanding
advantage of this methodology is that samples with very different
sequencing depth (from 80,000 to more than 7,000,000 reads,
Fig. 1) can be used for the analysis whereas in other methodologies
they need to be discarded in order to avoid biases [20].
Previous High-throughput Studies in Pterygium
A few previous studies had applied high-throughput techniques
to study the transcriptomics of pterygium. For instance, the gene
expression of pterygium was compared to that of normal
autologous conjuntiva, finding a significant increase of fibronectin,
CD24, MIP-4, and NGAL in the pterygium lesions [21,22].
Figure 2. Histogram showing the number of sequences aligned for each of the 40 experimental samples (sequencing depth).
Numbers represent individual donors and the 4 bars from each donor correspond to untreated control, and pterygium cells treated for 24 h with 50,
200, and 500 mg/ml doxycycline (left to right). There is a large variation in sequencing depth ranging from 82,040 reads for the less represented (cells
from patient number 7, treated with 500 mg/ml doxycycline) to 7,653,010 reads for the best represented (cells from patient number 6, treated with
50 mg/ml doxycycline).
doi:10.1371/journal.pone.0039359.g002
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with pre-existing data on human cornea, limbus, and conjunctiva,
finding that pterygium markers closely resemble those of
conjunctival and limbal cells [23]. A recent paper has shown that
pterygium presents aberrant DNA methylation patterns in regions
close to matrix remodelling genes such as TGM-2, MMP-2 and
CD24 [24]. Our study is the first to analyze mRNA and protein
changes produced by a drug treatment on pterygium cells.
Our cultured cells were positive for vimentin and negative for
epithelial and endothelial markers. Therefore our first impulse was
to classify them as fibroblasts. Nevertheless, Dushku and Reid
showed that pterygium originates from altered limbal epithelial
basal cells which express vimentin but do not stain for keratins
[25], so our primary cultures seem to represent the characteristic
cells of pterygium.
Doxycycline Action on the Mitochondria
Doxycycline has been used in the past as a reversible inhibitor of
mitochondrial translation [26–28]. Doxycycline occupies an
important tRNA binding site on the 30S ribosome subunit, thus
preventing the attachment of amino acyl tRNAs and terminating
the translation process. Depending on the cell type, different
mechanisms are activated [29]. This translation inhibition has
been associated with cell arrest, apoptosis/necrosis, and cell
detachment due to activation of caspase 3, 8, and 9, but also to
caspase-independent mechanisms [29–32]. Interestingly, doxycy-
cline concentrations achievable in serum seem to be more toxic for
tumors than for normal cells [33]. To the best of our knowledge,
our study provides the first evidence of doxycycline acting as a
selective inhibitor of mitochondrial genes’ transcription. The
inhibition is potent and raises the question of whether the
recognized effect of doxycycline as an inhibitor of mitochondrial
protein synthesis is due, at least in part, to the inhibition of the
transcription of mitochondrial encoded genes rather than to its
binding to the ribosomes’ active site.
Nonetheless, doxycycline pretreatment has been shown to
counteract the apoptosis and ER stress responses induced by
doxorubicin in mouse heart and testis [34,35], probably through a
Figure 3. Experimental demonstration that a correct normalization protocol was applied to ultrasequencing data. Representation of
the expression levels in the Y chromosome in a male (A) and a female (B) patient. Each dark line represents expression of a particular exon along the
length of the chromosome. The few lines observed in females correspond to repetitive regions of the genome. Expression levels for 3 representative
genes: H19 (C,D), clusterin (E,F), and matrix metalloproteinase 2 (G,H) as they appear before (C,E,G) and after (D,F,H) application of our normalization
protocol. Labeling of the 40 samples is the same as in Fig.1. Normalization success can be appreciated since individual variations are larger than
treatment-induced changes in these genes.
doi:10.1371/journal.pone.0039359.g003
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showing and increase in prosurvival molecules such as IL6,
VEGFA, p21, or RelA. A short time exposure to doxycycline
would provoke a transient mitochondrial damage and ER stress
that would stimulate those survival factors that may protect the
cells from the following doxorubicin insult. However in our
experimental paradigm those survival factors seem to be
overwhelmed by the production of proapoptotic factors such as
CHOP, BAX, and caspase activation.
Endoplasmic Reticulum Stress Response Pathway
ER stress is a cellular response to disturbances in the normal
function of the ER which is conserved in all mammalian species, as
well as in yeast and worms [36]. Accumulation of unfolded
proteins in the ER lumen results in activation of a common
response to this stress situation called the unfolded protein
response (UPR), which is aimed initially at compensating for
damage trying to restore normal function of the cell by halting
protein translation and activating the signaling pathways that lead
Figure 4. Hierarchical clustering (Manhattan plot) of all samples (columns) and the 332 genes which experienced larger changes
upon treatment with doxycycline (lines). All the controls tend to cluster together (left hand side) indicating a good normalization technique.
Red color expresses low expression levels and yellow designates high expression levels.
doi:10.1371/journal.pone.0039359.g004
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protein folding, but can eventually trigger cell death if ER stress is
severe or prolonged [37]. There are three main signaling systems
initiated by UPR through ER stress sensors, including Eukaryotic
translation initiation factor 2-alpha kinase 3 (eIF2AK3), Activating
transcription factor 6 (ATF-6 alpha), and Endoplasmic reticulum
to nucleus signaling 1 (IRE1) [36]. In normal conditions these
proteins are inactivated by Heat shock 70 kDa protein 5 (GRP78).
Accumulation of unfolded proteins leads to GRP78 binding to
them, resulting in release and activation of eIF2AK3, ATF-6 alpha
and IRE1 [37–40].
Activation of eIF2AK3 induces translation of Activating
transcription factor 4 (ATF-4), which is able to induce
transcription of Homocysteine-inducible, endoplasmic reticulum
stress-inducible, ubiquitin-like domain member 1 (HERP),
DNA-damage-inducible transcript 3 (C/EBP zeta), GRP78
and Protein phosphatase 1, regulatory (inhibitor) subunit 15A
(GADD34). All of them were upregulated by doxycycline
treatment.
Moreover, ATF-6 has been shown to translocate to the nucleus
and induce transcription of ER degradation enhancer, mannosi-
dase alpha-like 1 (EDEM), HERP, C/EBP zeta, X-box binding
protein 1 (XBP1), GRP78, and DnaJ (Hsp40) homolog, subfamily
C, member 3 (DNAJC3). Again all of them were upregulated by
doxycycline treatment.
In addition, active IRE1 splices XBP1 mRNA to promote
translation of XBP1, which translocates to the nucleus and
activates transcription of GRP78, Endoplasmin, Protein disulfide
isomerase family A, member 6 (ERP5), EDEM, HERP, C/EBP
zeta, Der1-like domain family, members 1, 2 and 3 (Derlin1,
Derlin-2 and Derlin-3). EDEM, HERP, Derlin1, Derlin-2 and
Derlin-3 promote ER-associated protein degradation, ERP5,
Endoplasmin and GRP78 stimulate protein folding. Doxycycline
treatment augmented the expression of all these genes.
In agreement with the results shown above, we also found an
increase in the transcription of GADD34 and DNAJC3, which
promote negative feed-back loops leading to restoration of
protein translation. However, when the restoration of homeo-
stasis is not achieved within a certain time lapse the UPR
switches to apoptosis promotion. Despite the translational block
produced by PERK activation, certain genes can bypass this
block. An example is the proapoptotic protein CHOP
(CCAAT/2enhancer-binding protein homologous protein)
which is upregulated by ATF4 (activating transcription factor
4). CHOP causes downregulation of the anti-apoptotic mito-
chondrial protein Bcl-2 [41], favoring a pro-apoptotic drive at
the mitochondria by proteins that cause mitochondrial damage,
cytochrome c release, and caspase 3 activation. The doxycy-
cline-mediated increase on the transcription of CHOP suggests
that the proapoptotic switch has been produced. Moreover, C/
EBP zeta, which is activated by IRE1 and leads to decreased
Bcl-2 transcription [42], is also upregulated by doxycycline.
Consistently, the expression of the pro-apoptotic molecule BAX
is also increased, supporting the idea of activation of apoptosis
in pterygium cells by doxycycline.
Extracellular Matrix and Integrins
Integrins and integrin receptors regulate many aspects of cell
physiology, being of particular importance in cell adhesion and
migration. These two processes depend on packing of actin
cytoskeleton into adhesive and protrusive organelles in response to
extracellular signals. In normal epithelia, alpha/beta integrins
function as receptors for the laminin family of extracellular matrix
proteins (such as laminin 1 and laminin 5) and mediate the stable
attachment of epithelial cells to the underlying basement
membrane [43].
The function of some integrins, such as alpha-6/beta-4 integrin,
is altered substantially as normal epithelia undergo malignant
transformation and progress to invasive carcinoma [44]. Cooper-
ative signaling between integrins and v-Erb-b2 erythroblastic
leukemia viral oncogene homologs 2 and 3 (ErbB2 and ErbB3) is
required to promote PI3K activation. This activation is mediated
through GAB1 [45]. Alpha-6/beta-4 integrin can also form
signaling complexes with specific growth factor receptors that act
synergistically to activate PI3K [44,46]. A signaling pathway
involving EGFR, ErbB2, ErbB3, phosphatidylinositol 3-kinase
Table 1. Ultrasequencing values for mitochondrial genes.
Gene name Ensembl number Fold change
50 mg/mL Doxycycline 200 mg/mL Doxycycline 500 mg/mL Doxycycline
MT-ATP6 ENSG00000198899 21.27 21.45 21.75
MT-CO1 ENSG00000198804 22.04 22.56 22.94
MT-CO2 ENSG00000198712 21.20 21.56 21.96
MT-CO3 ENSG00000198938 21.49 21.72 22.38
MT-CYB ENSG00000198727 21.75 22.33 22.86
MT-ND1 ENSG00000198888 21.67 21.92 22.50
MT-ND2 ENSG00000198763 21.32 21.39 21.92
MT-ND3 ENSG00000198840 21.72 22.27 22.70
MT-ND4 ENSG00000198886 21.64 21.89 22.38
MT-ND4L ENSG00000212907 21.56 22.00 22.38
MT-ND5 ENSG00000198786 21.47 21.79 22.27
MT-ND6 ENSG00000198695 21.54 21.92 22.44
MTRNR1 ENSG00000211459 2.60 3.08 3.33
MTRNR2 ENSG00000210082 1.28 1.36 1.64
Values are represented as the mean fold change of 10 patients with respect to untreated controls.
doi:10.1371/journal.pone.0039359.t001
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D1 is essential for the maintenance of survival, mitosis, and
invasiveness of human lung adenocarcinoma cell lines as well as to
evade apoptosis [47].
In our experiments, doxycycline treatment decreased the
expression of multiple members involved in the interaction
between the cell and the extracellular membrane, including
ligands such as laminin 1, laminin 5, and THBS1, integrins such as
b1 and ErbB3, intracellular mediators such as vinculin, GAB1,
PI3K p85, and EIF4E3, suggesting that anoikis may be another
mechanism by which doxycycline exerts its actions on pterygium
cells.
Figure 5. Schematic cartoon of the main pathways involved in the endoplasmic reticulum (ER) stress response. Proteins are
translocated directly from the ribosome into the ER and protein folding takes place with the help of specific chaperones. If folding is correct, the
proteins follow their path to the Golgi complex and the secretory pathway. If misfolded proteins accumulate in the ER lumen, the UPR can be
triggered and signals will be sent to the nucleus and apoptosis could be induced through CHOP. All the proteins represented in the cartoon are
significantly upregulated by doxycycline treatment.
doi:10.1371/journal.pone.0039359.g005
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Several growth factors such as VEGF and MANF and
interleukins such as IL-6 were elevated in pterygium cells exposed
to doxycycline.
VEGF has attracted much attention in the study of pterygium
lesions since they are highly vascularised and upregulation of
VEGF has been reported in pterygia when compared to normal
conjunctiva [48]. In addition, women with a polymorphism in the
VEGF gene (VEGF-460) have a 2.5-fold increased risk of
developing pterygium [49]. These observations were instrumental
in designing clinical trials where bevacizumab, the humanized
blocking antibody against VEGF, was applied to pterygium lesions
[9,10]. The fact that doxycycline treatment results in a higher
expression of VEGF suggests that this may be a compensatory
reaction of the cells whose survival is compromised by the decrease
in mitochondrial protein synthesis and elevated ER stress.
In the same line of thought, MANF acts as a growth factor for
astrocytes and other neural cells but also as a protective factor
against ER stress [50]. Since we have reported a huge increase in
genes related to the ER stress response upon doxycycline
treatment, MANF expression may be increased to try to
compensate for these deleterious circumstances.
IL-6 is a proinflammatory cytokine which is upregulated in
pterygium by UV light exposure and might be part of the
pathological pathway leading to the formation of the lesion [51].
Elevation of this cytokine is related to increases in angiogenesis,
cell proliferation, invasion potential, and inflammation. The
upregulation of IL-6 after treatment with doxycycline may be
also part of the survival program of the pterygium cells faced by
the harsh conditions created by the antibiotic.
Cell Cycle Arrest
Doxycycline has been shown to induce cell cycle arrest,
although this effect is dependent on the cell line studied [29,52].
Likewise, induction of p53 gene expression in cancer cells can lead
to both cell cycle arrest and apoptosis. In addition, the expression
of the proapoptotic molecule Bax is up-regulated following an
increase on p53 levels [53]. In our hands, doxycycline treatment
on pterygium culture increased the expression of p53 and several
others CDKs (CDKN1A, CDK2AP2), as well as the proapoptotic
protein Bax, providing an additional mechanism to the observed
changes.
In conclusion, we have shown that doxycycline elicits a strong
dose-dependent response in pterygium cells inducing a number of
intracellular pathways such as mitochondrial gene expression, the
ER stress pathway, genes related to the extracellular matrix
environment, growth factors, interleukins, and cell cycle related
proteins. These changes can explain the reduction in pterygium
growth previously reported in a mouse model for this antibiotic
[11] and provide the theoretical basis to pursue treatment of
pterygium patients with doxycycline. Current clinical trials are
under way to test whether this treatment is efficient in humans.
Materials and Methods
Patients and Primary Culture
Use of pterygium specimens was approved by our Institutional
Review Board (Comite ´E ´tico de Investigacio ´n Clı ´nica de La Rioja,
CEICLAR). All patients provided written informed consent and
the specimens were handled in accordance with the Declaration of
Helsinki. Ten consecutive patients that underwent surgical
removal of their primary pterygium were recruited. These
included 6 males and 4 females with a medium age of 44.367.8
Table 2. Ultrasequencing values for integrins and extracellular matrix-related genes.
Gene family Gene name Ensembl number Fold change
50 mg/mL Doxyc. 200 mg/mL Doxyc.
500 mg/mL
Doxyc.
Integrins CTGF ENSG00000118523 22.04 22.70 24.55
CRELD1 ENSG00000163703 2.60 3.40 3.47
CYR61 ENSG00000142871 21.82 21.92 22,33
ICAM1 ENSG00000090339 2.13 3.40 3.89
ITGA4 ENSG00000115232 21.33 22.04 21.64
ITGA5 ENSG00000161638 1.87 2.26 2.31
ITGB1 ENSG00000150093 21.16 21.69 21.35
ITGB8 ENSG00000105855 21.54 22.50 21.89
ITGBL1 ENSG00000198542 21.43 21.72 22.13
Integrin-interacting proteins SLC3A2 ENSG00000168003 2.75 3.22 3.15
THBS1 ENSG00000137801 21.39 21.67 21.85
SVEP1 ENSG00000165124 21.44 21.71 22.06
Collagens COL12A1 ENSG00000111799 21.32 21.92 21.82
COL5A2 ENSG00000204262 21.25 21.47 21.61
Extracellular matrix LAMB1 ENSG00000091136 21.52 22.04 22.33
LAMA3 ENSG00000053747 21.47 21.41 21.32
LAMA4 ENSG00000112769 21.33 21.82 21.79
SPARC ENSG00000113140 21.09 21.18 21.37
Values are represented as the mean fold change of 10 patients with respect to untreated controls.
doi:10.1371/journal.pone.0039359.t002
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e39359Figure 6. Gene expression quantification by ultrasequencing (open bars) and qRT-PCR (solid bars) for several sample genes
involved in different pathways such as mitochondrial genes (A-C), endoplasmic reticulum stress response (D-F), members of the
integrin family (G-I), and genes related with the cell cycle (J-L). Bars represent fold increase (or decrease) with respect to untreated controls
6 SEM for 10 independent samples. Statistically significant differences with untreated controls are represented by asterisks (for ultrasequencing data)
or the pound sign (for qRT-PCR). **: p,0.01; ***: p,0.001; #:p ,0.05; ##:p ,0.01; ###:p ,0.001.
doi:10.1371/journal.pone.0039359.g006
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(both women) and 8 were immigrants from South America. The
excised pterygia were transferred to the laboratory for establishing
cell cultures as previously described [11]. Briefly, the pterygium
specimen was minced into small pieces and cultured for 3 days in
DMEM/F-12 medium supplemented with 10% fetal calf serum,
200 mM L-glutamine, 0.5% DMSO, and 1% penicillin/strepto-
mycin/amphotericin (all culture reagents are from Invitrogen,
Carlsbad, CA). Once the cells had migrated from the explants and
attached to the dish surface, the explant fragments were removed
and the medium changed to keratinocyte-serum free medium with
5% fetal calf serum, and 1% penicillin/streptomycin/amphoter-
icin. When the cells reached 80% confluency, they were passed to
fresh dishes using 0.25% trypsin. Medium was renewed every 2–3
days and replaced with fresh medium 24 h before adding the
antibiotic. All experiments were performed with cells on passages 3
to 5. For each patient, cells were subjected to 4 treatments: 0
(control), 50, 200, and 500 mg/ml doxycycline (Vibravenosa,
Pfizer, Alcobendas, Spain) for 24 h.
Immunofluorescence and Confocal Microscopy
Prior to doxycycline treatment, some cells were cultured in glass
coverslips overnight, fixed with 10% buffered formalin for 10 min,
permeabilized with 0.1% triton X-100 in PBS for 10 min, and
exposed to a mix of 3 primary antibodies overnight at 4uC. These
primary antibodies included mouse anti-vimentin (1:40, Sigma,
Madrid, Spain), rabbit anti-cytokeratin 4 (1:100, Abcam, Cam-
bridge, UK), and goat anti-CD31 (1:50, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA). Following vigorous washes, the second layer
was added for 2 h at room temperature. Conjugated antibodies in
this second layer included Alexa 633 donkey anti-goat, Alexa 546
donkey anti-rabbit, and Alexa 488 donkey anti-mouse (1:200,
Invitrogen). After another series of washes, the coverslips were
mounted with DAPI-containing ProLong mounting medium
(Invitrogen). Paraffin sections of human uterus and appendix were
processed in parallel as positive controls. A confocal microscope
(Leica TCS SP5, Leica, Badalona, Spain) was used to visualize the
slides.
RNA Extraction
Total RNA was isolated from pterygium cell cultures using
TRIzol (Invitrogen), purified using an RNeasy Mini kit (Qiagen,
Valencia, CA), and treated with DNase I (Qiagen) following
manufacturer’s instructions.
cDNA Library Preparation and Ultrasequencing
Library preparation and ultrasequencing were performed
following Illumina’s (San Diego, CA) protocols. Most reagents
were also from Illumina.
First, the integrity and quality of total RNA were assessed with
the Experion Automated Electrophoresis system (BioRad, Hercu-
les, CA). Then, mRNA was isolated from 1 mg of total RNA using
poly-T oligo-attached magnetic beads. This mRNA was frag-
mented into pieces of approximately 200 bp using divalent cations
under elevated temperature. The cleaved RNA fragments were
reverse transcribed into first strand cDNA using reverse transcrip-
tase and random primers. Next, the second strand was synthesized
using DNA polymerase I and RNAse H. These double-stranded
cDNA fragments were end-repaired by T4 DNA polymerase and
Klenow DNA polymerase, and phosphorylated by T4 polynucle-
otide kinase. The cDNA products were incubated with Klenow
DNA polymerase to generate 39 Adenine overhangs, therefore
allowing ligation to Illumina indexing adapters to the double
stranded cDNA ends. The adapter-ligated products were purified
with Ampure XP magnetic beads (Agencourt Bioscience Corpo-
ration, Beverly, MA, USA) and libraries were amplified by 15
cycles of PCR with Phusion DNA polymerase (Finnzymes
Reagents, Vantaa, Finland). Constructed libraries were validated
and quantified using BioRad’s automated electrophoresis system
Experion and qPCR respectively. Pools of 6 indexed libraries were
mixed (multiplexed) at equimolar ratios to yield a total oligonu-
cleotide mix concentration of 10 nM. Finally the resulting libraries
were sequenced on the Genome Analyzer IIx platform (Illumina)
to generate 150 bp single reads. Six pooled indexed libraries were
sequenced in each flow cell lane.
Data Treatment
Raw sequence data in fastq format were processed through a
number of sequential steps:
1. Aggressive adapter removal: adapter sequences were removed
from the raw sequences with an ad-hoc script using a non-
conservative approach. Thus, even the shortest representations
(one nucleotide) were eliminated.
2. mRNA alignment to DNA: alignment was performed by
Tophat (an intron aware wrapper of Bowtie DNA aligner).
Results were sorted and indexed using Samtools.
3. Coverage vectors for each sample were extracted under R
statistical environment using Rsamtools library. Human GTF
annotation from Ensembl was applied as reference for the exon
genomic ranges, parsed into R data structures. Exon expression
was calculated as the median coverage for every exon genomic
range as stated by annotation. Exon expression data from our
40 different samples were normalized by quantile normaliza-
tion and locus expression was calculated by simple addition of
Figure 7. Correlation analysis between values obtained
through ultrasequencing (abscises) and through qRT-PCR
(ordinates). Pearsons coefficient is 0.9110 and R
2=0.8299; p,0.0001.
doi:10.1371/journal.pone.0039359.g007
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4. Samples were grouped by patient and every locus expression in
the group was scaled in the interval [0,1] in order to correct for
the different response ranges observed for the same gene in
different genetic backgrounds.
5. Library siggenes in R was applied to select the differentially
expressed loci using the FDR-based SAM method.
Resulting data were submitted to GEO (http://www.ncbi.nlm.
nih.gov/geo) and are available with accession number GSE34736.
Heatmaps
The 332 genes whose expression was most regulated by
doxycycline, with a FDR lower than 0.005, were represented as
a heatmap by using a Manhattan method for dissimilarity and a
ward method for hierarchical clustering, calculated in an R
environment.
Pathway/Network Analysis
The Reactome FI cytoscape plugin (www.reactome.org) and the
Genemania cytoscape plugin (www.genemania.org) [54] were used
to identify enriched pathways and networks regulated by
doxycycline treatment.
Statistics
GraphPad Prism v5 was used for all statistics. Two-way
ANOVA was used to analyze qRT-PCR and ultrasequencing
data. Correlation analysis was used to compare ultrasequencing
and qRT-PCR data. Differences were considered statistically
significant when p,0.05.
Confirmation of the Sequencing Results
Gene products whose expression was significantly changed upon
application of doxycycline were chosen for further confirmation.
cDNA was synthesized by reverse transcription of 1 mg of total
RNA using the SuperScript III First-Strand Synthesis kit
(Invitrogen) in a total volume of 20 ml according to the
manufacturer’s instructions and was amplified by qRT-PCR using
Taqman probes (Table 3) in a 7300 Real Time PCR System
(Applied Biosystems, Carlsbad, CA) and their gene expression
calculated using absolute quantification by interpolation into a
standard curve [55]. All values were divided by the expression of
the house keeping gene, GAPDH, to avoid potential pipetting
errors. Some secreted proteins such as IL-6, MANF and VEGF-A
were quantified in the supernatant of the cultures by commercially
available ELISA kits (Uscn, Life Science, Inc. Wuhan, China).
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